Prevention of Post-Cardiac Surgery Acute Kidney Injury by Proton Pump Inhibitor - Trial NCT06154226
Access comprehensive clinical trial information for NCT06154226 through Pure Global AI's free database. This Phase 4 trial is sponsored by The University of Texas Health Science Center, Houston and is currently Not yet recruiting. The study focuses on Acute Kidney Injury. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
The University of Texas Health Science Center, Houston
Timeline & Enrollment
Phase 4
Dec 01, 2023
Feb 01, 2025
Primary Outcome
The area under the curve (AUC) of urinary kidney injury biomarkers KIM-1 above baseline within 24 hours postoperatively
Summary
The purpose of this study is to determine whether perioperative intravenous administration of
 pantoprazole will improve kidney function parameters following cardiac surgery with
 cardiopulmonary bypass compared to famotidine and to determine whether perioperative
 intravenous administration of pantoprazole will decrease the incidence of postoperative Acte
 Kidney Injury (AKI) and major adverse kidney events (MAKE)
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06154226
Non-Device Trial